Name: Single-Use Bioreactors Market by Product [System (By Scale), Bags (2D, 3D), Assemblies], Type (Stirred Tank), Cell Type (Mammalian, Bacterial, Yeast), Molecule (mAbs, Vaccines, CGT), Process Mode, Application, Competition, Region - Global Forecast to 2031
Brand: MarketsandMarkets
SKU: BT2863
Price: 4950 USD
Availability: InStock

1 INTRODUCTION 42 1.1 STUDY OBJECTIVES 42 1.2 MARKET DEFINITION 42 1.3 STUDY SCOPE 42 1.3.1 MARKET SEGMENTATION & REGIONS COVERED 43 1.3.2 INCLUSIONS & EXCLUSIONS 44 1.3.3 YEARS CONSIDERED 45 1.3.4 CURRENCY CONSIDERED 45 1.4 STAKEHOLDERS 45 1.5 SUMMARY OF CHANGES 46 2 EXECUTIVE SUMMARY 47 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 47 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 49 2.3 DISRUPTIVE TRENDS IN SINGLE-USE BIOREACTORS MARKET 50 2.4 HIGH-GROWTH SEGMENTS 51 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 52 3 PREMIUM INSIGHTS 53 3.1 GLOBAL SINGLE-USE BIOREACTORS MARKET SNAPSHOT 53 3.2 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT AND COUNTRY, 2025 54 3.3 SINGLE-USE BIOREACTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55 3.4 SINGLE-USE BIOREACTORS MARKET SHARE, BY END USER, 2026 VS. 2031 (%) 56 4 MARKET OVERVIEW 57 4.1 INTRODUCTION 57 4.2 MARKET DYNAMICS 57 4.2.1 DRIVERS 58 4.2.1.1 Rising adoption of flexible SUB platforms among CDMOs, CMOs, and SMEs 58 4.2.1.2 Operational advantages over conventional bioreactors 59 4.2.1.3 Reduced upfront capital investment 60 4.2.1.4 Reduced water and energy consumption 61 4.2.1.5 Expansion of biologics and biosimilar manufacturing demand 62 4.2.2 RESTRAINTS 64 4.2.2.1 Concerns related to extractables and leachables 64 4.2.2.2 Regulatory and compliance requirements for SUB implementation 64 4.2.2.3 Impact of PFAS restrictions on product development 65 4.2.3 OPPORTUNITIES 66 4.2.3.1 Untapped growth potential in emerging biomanufacturing economies 66 4.2.3.2 Shift towards hybrid biomanufacturing 67 4.2.4 CHALLENGES 67 4.2.4.1 Lack of standardization 67 4.2.4.2 Waste disposal burden and sustainability pressure 68 4.2.4.3 Risk of SU bag leakage and integrity failure 69 4.3 UNMET NEEDS & WHITE SPACES 70 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 70 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 71 5 INDUSTRY TRENDS 72 5.1 PORTER’S FIVE FORCES ANALYSIS 72 5.1.1 BARGAINING POWER OF SUPPLIERS 73 5.1.2 BARGAINING POWER OF BUYERS 73 5.1.3 THREAT OF NEW ENTRANTS 73 5.1.4 THREAT OF SUBSTITUTES 73 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 74 5.2 MACROECONOMIC OUTLOOK 74 5.2.1 INTRODUCTION 74 5.2.2 GDP TRENDS & FORECAST 74 5.2.3 TRENDS IN GLOBAL SINGLE-USE BIOREACTORS INDUSTRY 75 5.3 VALUE CHAIN ANALYSIS 76 5.4 ECOSYSTEM ANALYSIS 77 5.5 PRICING ANALYSIS 80 5.5.1 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY KEY PLAYER, 2023–2025 81 5.5.2 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY REGION, 2023–2025 83 5.6 TRADE ANALYSIS 85 5.6.1 IMPORT SCENARIO (HS CODE 841989) 85 5.6.2 EXPORT SCENARIO (HS CODE 841989) 87 5.7 KEY CONFERENCES & EVENTS, 2026–2027 89 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 89 5.9 INVESTMENT & FUNDING SCENARIO 91 5.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE 91 5.10 IMPACT OF 2025 US TARIFFS ON SINGLE-USE BIOREACTORS MARKET 92 5.10.1 INTRODUCTION 92 5.10.2 KEY TARIFF RATES 92 5.10.3 PRICE IMPACT ANALYSIS 93 5.10.4 IMPACT ON COUNTRIES/REGIONS 94 5.10.4.1 US 94 5.10.4.2 Europe 94 5.10.4.3 Asia Pacific 94 5.10.5 IMPACT ON END-USE INDUSTRIES 95 5.10.5.1 Pharmaceutical & biotechnology companies 95 5.10.5.2 CROs & CMOs 96 5.10.5.3 Academic & research institutes 96 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS 97 6.1 TECHNOLOGY ANALYSIS 97 6.1.1 KEY EMERGING TECHNOLOGIES 97 6.1.1.1 Fermentation 97 6.1.1.2 Continuous bioprocessing 97 6.1.1.3 3D cell culture 98 6.1.2 COMPLEMENTARY TECHNOLOGIES 98 6.1.2.1 Automation & control 98 6.1.2.2 Data analytics & machine learning 98 6.1.3 ADJACENT TECHNOLOGIES 99 6.1.3.1 Filtration 99 6.1.3.2 Cell separation 99 6.2 TECHNOLOGY/PRODUCT ROADMAP 99 6.3 PATENT ANALYSIS 100 6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR SINGLE-USE BIOREACTOR PATENTS 100 6.4 FUTURE APPLICATIONS 103 6.5 IMPACT OF AI/GEN AI ON SINGLE-USE BIOREACTORS MARKET 104 6.5.1 BEST PRACTICES IN SINGLE-USE BIOREACTORS WORKFLOW 105 6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN SINGLE-USE BIOREACTORS MARKET 105 6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 106 6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN SINGLE-USE BIOREACTORS MARKET 106 7 SUSTAINABILITY & REGULATORY LANDSCAPE 107 7.1 REGIONAL REGULATIONS & COMPLIANCE 107 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 107 7.1.2 REGULATORY FRAMEWORK 110 7.1.2.1 North America 110 7.1.2.2 Europe 111 7.1.2.3 Asia Pacific 111 7.1.2.4 Rest of the World 111 7.1.3 INDUSTRY STANDARDS 111 7.2 SUSTAINABILITY INITIATIVES 112 7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 113 7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 113 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 115 8.1 DECISION-MAKING PROCESS 115 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 115 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 115 8.2.2 KEY BUYING CRITERIA, BY END USER 117 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 119 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 119 8.5 MARKET PROFITABILITY 119 9 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT 120 9.1 INTRODUCTION 121 9.2 SINGLE-USE BIOREACTOR SYSTEMS 121 9.2.1 ≤10 L BIOREACTORS 126 9.2.1.1 High-throughput process development and scale-down studies to support market growth 126 9.2.2 11–100 L BIOREACTORS 129 9.2.2.1 Increasing pilot-scale and clinical manufacturing to support market growth 129 9.2.3 101–500 L BIOREACTORS 133 9.2.3.1 Flexible scale-up from clinical to early commercial production to propel market growth 133 9.2.4 501–1,500 L BIOREACTORS 136 9.2.4.1 Expanding late-stage and commercial biologics capacity to support market growth 136 9.2.5 >1,500 L BIOREACTORS 140 9.2.5.1 Large-scale single-use commercialization to strengthen market position 140 9.3 SINGLE-USE BAGS 143 9.3.1 2D SINGLE-USE BAGS 146 9.3.1.1 Low-volume flexibility and expanding cell therapy applications to support market growth 146 9.3.2 3D SINGLE-USE BAGS 150 9.3.2.1 Large-volume biologics production to support market growth 150 9.4 SINGLE-USE ASSEMBLIES 153 9.4.1 INCREASING ADOPTION OF CLOSED FLUID PATHS TO SUPPORT MARKET GROWTH 153 9.5 OTHER PRODUCTS 156 10 SINGLE-USE BIOREACTORS MARKET, BY TYPE 160 10.1 INTRODUCTION 161 10.2 STIRRED-TANK SINGLE-USE BIOREACTORS 161 10.2.1 BROAD SCALABILITY AND COMPATIBILITY WITH INTENSIFIED CELL CULTURE TO SUPPORT MARKET GROWTH 161 10.3 WAVE-INDUCED SINGLE-USE BIOREACTORS 165 10.3.1 INCREASING ADOPTION IN CELL THERAPY AND SEED-TRAIN APPLICATIONS TO SUPPORT MARKET GROWTH 165 10.4 FIXED-BED SINGLE-USE BIOREACTORS 169 10.4.1 HIGH-DENSITY ADHERENT CELL AND VIRAL VECTOR PRODUCTION TO DRIVE FASTEST MARKET GROWTH 169 10.5 BUBBLE-COLUMN SINGLE-USE BIOREACTORS 173 10.5.1 IMPELLER-FREE MIXING AND EXPANDING MICROBIAL APPLICATIONS TO SUPPORT MARKET GROWTH 173 10.6 OTHER SINGLE-USE BIOREACTORS 176 11 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE 180 11.1 INTRODUCTION 181 11.2 MONOCLONAL ANTIBODIES 181 11.2.1 EXPANDING THERAPEUTIC PIPELINES AND BIOSIMILAR PRODUCTION TO SUPPORT SEGMENT DOMINANCE 181 11.3 VACCINES 185 11.3.1 EXPANDING VACCINE PIPELINES AND FLEXIBLE MANUFACTURING REQUIREMENTS TO SUPPORT MARKET GROWTH 185 11.4 CELL & GENE THERAPY 188 11.4.1 EXPANDING ADVANCED THERAPY PIPELINES AND MANUFACTURING INVESTMENTS TO SUPPORT MARKET GROWTH 188 11.5 THERAPEUTIC PROTEINS & PEPTIDES 192 11.5.1 INCREASING DEMAND FOR RECOMBINANT PROTEINS AND PEPTIDE THERAPEUTICS TO SUPPORT MARKET GROWTH 192 12 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE 196 12.1 INTRODUCTION 197 12.2 MAMMALIAN CELLS 197 12.2.1 HIGH DEMAND FOR COMPLEX BIOLOGICS TO SUPPORT SEGMENT DOMINANCE 197 12.3 BACTERIAL CELLS 201 12.3.1 EXPANDING PLASMID DNA AND RECOMBINANT PROTEIN PRODUCTION TO SUPPORT MARKET GROWTH 201 12.4 YEAST CELLS 204 12.4.1 INCREASING USE IN RECOMBINANT PROTEIN AND VACCINE PRODUCTION TO SUPPORT MARKET GROWTH 204 12.5 OTHER CELLS 208 13 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION 212 13.1 INTRODUCTION 213 13.2 BIOPRODUCTION 213 13.2.1 COMMERCIAL BIOLOGICS PRODUCTION AND FLEXIBLE MANUFACTURING CAPACITY TO REINFORCE SEGMENT LEADERSHIP 213 13.3 PROCESS DEVELOPMENT 217 13.3.1 ACCELERATED PROCESS OPTIMIZATION TO DRIVE GROWTH OF PROCESS DEVELOPMENT APPLICATIONS 217 13.4 RESEARCH & DEVELOPMENT 220 13.4.1 GROWING ADOPTION OF INTENSIFIED BIOPROCESSING TO DRIVE FASTEST GROWTH IN PERFUSION-BASED MANUFACTURING 220 14 SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE 224 14.1 INTRODUCTION 225 14.2 FED-BATCH PROCESS MODE 225 14.2.1 COMMERCIAL BIOLOGICS MANUFACTURING TO CONTINUE TO POSITION FED-BATCH AS LARGEST PROCESS SEGMENT 225 14.3 BATCH PROCESS MODE 229 14.3.1 PROCESS DEVELOPMENT AND SMALL-SCALE BIOLOGICS PRODUCTION TO SUSTAIN DEMAND FOR BATCH PROCESSING 229 14.4 PERFUSION/CONTINUOUS PROCESS MODE 232 14.4.1 GROWING ADOPTION OF INTENSIFIED BIOPROCESSING TO DRIVES FASTEST GROWTH IN PERFUSION-BASED MANUFACTURING 232 15 SINGLE-USE BIOREACTORS MARKET, BY END USER 236 15.1 INTRODUCTION 237 15.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 237 15.2.1 COMMERCIAL BIOLOGICS PRODUCTION AND FLEXIBLE MANUFACTURING CAPACITY TO REINFORCE SEGMENT LEADERSHIP 237 15.3 CROS & CDMOS 241 15.3.1 BIOLOGICS OUTSOURCING TO DRIVE GROWTH AMONG CROS AND CMOS 241 15.4 ACADEMIC & RESEARCH INSTITUTES 244 15.4.1 EXPANDING LIFE SCIENCE RESEARCH TO CONTINUE TO SUPPORT DEMAND FROM ACADEMIC & RESEARCH INSTITUTES 244 16 SINGLE-USE BIOREACTORS MARKET, BY REGION 248 16.1 INTRODUCTION 249 16.2 NORTH AMERICA 249 16.2.1 US 254 16.2.1.1 US to dominate North American market during study period 254 16.2.2 CANADA 258 16.2.2.1 Public biomanufacturing investment and advanced-therapy capacity expansion to support market growth 258 16.3 EUROPE 261 16.3.1 GERMANY 265 16.3.1.1 Strong bioprocessing ecosystem and expanding therapeutic pipelines to support market growth 265 16.3.2 UK 269 16.3.2.1 Public funding and advanced-therapy manufacturing to support market growth 269 16.3.3 FRANCE 272 16.3.3.1 Strong bioprocessing supply base and biopharmaceutical investments to support market growth 272 16.3.4 ITALY 276 16.3.4.1 Strong pharmaceutical manufacturing and advanced-therapy capabilities to support market growth 276 16.3.5 SPAIN 280 16.3.5.1 Expanding biotechnology R&D and CDMO capacity to support market growth 280 16.3.6 REST OF EUROPE 283 16.4 ASIA PACIFIC 287 16.4.1 CHINA 293 16.4.1.1 Large biologics pipeline and commercial-scale single-use capacity to drive market growth 293 16.4.2 SOUTH KOREA 297 16.4.2.1 Large-scale CDMO capacity and export-oriented biopharmaceutical industry to support market growth 297 16.4.3 JAPAN 301 16.4.3.1 Biologics pipeline expansion and regenerative medicine commercialization to support market growth 301 16.4.4 INDIA 305 16.4.4.1 Export-oriented biopharmaceutical industry and policy support to drive market growth 305 16.4.5 AUSTRALIA 309 16.4.5.1 Clinical research funding and advanced-therapy manufacturing to support market growth 309 16.4.6 REST OF ASIA PACIFIC 312 16.5 LATIN AMERICA 316 16.5.1 BRAZIL 320 16.5.1.1 Public bioproduction investment and expanding vaccine capabilities to support market growth 320 16.5.2 MEXICO 324 16.5.2.1 Domestic biopharmaceutical capacity expansion to support market growth 324 16.5.3 REST OF LATIN AMERICA 327 16.6 MIDDLE EAST 331 16.6.1 GCC COUNTRIES 335 16.6.1.1 Saudi Arabia 338 16.6.1.1.1 National biotechnology strategy and commercial biopharma capacity to propel market growth 338 16.6.1.2 UAE 342 16.6.1.2.1 Vaccine manufacturing and regulatory ecosystem development to support market growth 342 16.6.1.3 Rest of GCC countries 345 16.6.2 REST OF MIDDLE EAST 348 16.7 AFRICA 352 16.7.1 VACCINE MANUFACTURING LOCALIZATION AND TECHNOLOGY TRANSFER TO SUPPORT MARKET GROWTH 352 17 COMPETITIVE LANDSCAPE 356 17.1 OVERVIEW 356 17.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 356 17.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SINGLE-USE BIOREACTORS MARKET 356 17.3 REVENUE ANALYSIS, 2021–2025 358 17.4 MARKET SHARE ANALYSIS, 2025 359 17.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 361 17.5.1 STARS 361 17.5.2 EMERGING LEADERS 361 17.5.3 PERVASIVE PLAYERS 362 17.5.4 PARTICIPANTS 362 17.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 363 17.5.5.1 Company footprint 363 17.5.5.2 Region footprint 364 17.5.5.3 Product footprint 365 17.5.5.4 Type footprint 366 17.5.5.5 Application footprint 367 17.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 368 17.6.1 PROGRESSIVE COMPANIES 368 17.6.2 RESPONSIVE COMPANIES 368 17.6.3 DYNAMIC COMPANIES 368 17.6.4 STARTING BLOCKS 368 17.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 370 17.6.5.1 Detailed list of key startups/SMEs 370 17.6.5.2 Competitive benchmarking of key startups/SMEs 372 17.7 COMPANY VALUATION & FINANCIAL METRICS 373 17.7.1 FINANCIAL METRICS 373 17.7.2 COMPANY VALUATION 373 17.8 BRAND/PRODUCT COMPARISON 374 17.9 COMPETITIVE SCENARIO 375 17.9.1 PRODUCT LAUNCHES 375 17.9.2 DEALS 376 17.9.3 EXPANSIONS 377 18 COMPANY PROFILES 378 18.1 KEY PLAYERS 378 18.1.1 SARTORIUS AG 378 18.1.1.1 Business overview 378 18.1.1.2 Products offered 379 18.1.1.3 Recent developments 381 18.1.1.3.1 Product launches 381 18.1.1.3.2 Deals 381 18.1.1.3.3 Expansions 382 18.1.1.4 MnM view 383 18.1.1.4.1 Key strengths 383 18.1.1.4.2 Strategic choices 383 18.1.1.4.3 Weaknesses & competitive threats 383 18.1.2 DANAHER CORPORATION 384 18.1.2.1 Business overview 384 18.1.2.2 Products offered 386 18.1.2.3 Recent developments 388 18.1.2.3.1 Product launches 388 18.1.2.3.2 Deals 388 18.1.2.3.3 Expansions 389 18.1.2.4 MnM view 390 18.1.2.4.1 Right to win 390 18.1.2.4.2 Strategic choices 390 18.1.2.4.3 Weaknesses & competitive threats 390 18.1.3 THERMO FISHER SCIENTIFIC INC. 391 18.1.3.1 Business overview 391 18.1.3.2 Products offered 393 18.1.3.3 Recent developments 394 18.1.3.3.1 Product launches 394 18.1.3.3.2 Deals 395 18.1.3.3.3 Expansions 396 18.1.3.4 MnM view 396 18.1.3.4.1 Right to win 396 18.1.3.4.2 Strategic choices 397 18.1.3.4.3 Weaknesses & competitive threats 397 18.1.4 MERCK KGAA 398 18.1.4.1 Business overview 398 18.1.4.2 Products offered 400 18.1.4.3 Recent developments 401 18.1.4.3.1 Product launches 401 18.1.4.3.2 Deals 401 18.1.4.3.3 Expansions 402 18.1.4.4 MnM view 403 18.1.4.4.1 Right to win 403 18.1.4.4.2 Strategic choices 403 18.1.4.4.3 Weaknesses & competitive threats 403 18.1.5 AVANTOR, INC. 404 18.1.5.1 Business overview 404 18.1.5.2 Products offered 406 18.1.5.3 Recent developments 407 18.1.5.3.1 Deals 407 18.1.5.3.2 Expansions 407 18.1.6 REPLIGEN CORPORATION 408 18.1.6.1 Business overview 408 18.1.6.2 Products offered 410 18.1.6.3 Recent developments 411 18.1.6.3.1 Deals 411 18.1.6.3.2 Expansions 411 18.1.7 GETINGE AB 412 18.1.7.1 Business overview 412 18.1.7.2 Products offered 414 18.1.7.3 Recent developments 415 18.1.7.3.1 Product launches 415 18.1.7.3.2 Deals 415 18.1.7.3.3 Expansions 416 18.1.8 EPPENDORF SE 417 18.1.8.1 Business overview 417 18.1.8.2 Products offered 418 18.1.8.3 Recent developments 419 18.1.8.3.1 Deals 419 18.1.8.3.2 Expansions 419 18.1.9 PARKER HANNIFIN CORPORATION 420 18.1.9.1 Business overview 420 18.1.9.2 Products offered 422 18.1.10 ENTEGRIS 423 18.1.10.1 Business overview 423 18.1.10.2 Products offered 425 18.1.11 SAINT-GOBAIN 426 18.1.11.1 Business overview 426 18.1.11.2 Products offered 427 18.1.11.3 Recent developments 428 18.1.11.3.1 Product launches 428 18.1.11.3.2 Expansions 428 18.1.12 CORNING INCORPORATED 429 18.1.12.1 Business overview 429 18.1.12.2 Products offered 430 18.1.13 LONZA 431 18.1.13.1 Business overview 431 18.1.13.2 Products offered 432 18.1.13.3 Recent developments 433 18.1.13.3.1 Deals 433 18.1.14 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L. 434 18.1.14.1 Business overview 434 18.1.14.2 Products offered 434 18.1.14.3 Recent developments 435 18.1.14.3.1 Product launches 435 18.1.14.3.2 Expansions 435 18.1.15 ZACROS CORPORATION 436 18.1.15.1 Business overview 436 18.1.15.2 Products offered 437 18.2 OTHER PLAYERS 438 18.2.1 ADOLF KÜHNER AG 438 18.2.2 OMNIBRX BIOTECHNOLOGIES PVT LTD. 439 18.2.3 NEW HORIZON BIOTECHNOLOGY, INC. 440 18.2.4 PBS BIOTECH, INC. 441 18.2.5 BBI-BIOTECH GMBH 442 18.2.6 ABEC, INC. 443 18.2.7 ESCO LIFESCIENCES GROUP 444 18.2.8 DISTEK, INC. 445 18.2.9 SATAKE MULTIMIX CORPORATION 446 18.2.10 CELL CULTURE COMPANY, LLC 447 18.2.11 MICRODIGITAL CO., LTD. 448 18.2.12 BIONET 449 18.2.13 MEISSNER FILTRATION PRODUCTS, INC. 450 18.2.14 SOLIDA BIOTECH GMBH 451 18.2.15 G&G TECHNOLOGIES, INC. 451 18.2.16 PHARMNXT BIOTECH 452 18.2.17 TOFFLON LIFE SCIENCE CO., LTD. 452 18.2.18 SHANGHAI LEPURE BIOTECH CO., LTD. 453 19 RESEARCH METHODOLOGY 454 19.1 RESEARCH DATA 454 19.1.1 SECONDARY DATA 455 19.1.1.1 Key secondary sources 455 19.1.1.2 Key data from secondary research 455 19.1.2 PRIMARY DATA 456 19.1.2.1 Key primary participants 456 19.1.2.2 Breakdown of primary interviews 456 19.1.2.3 Key data from primary sources 456 19.2 MARKET SIZE ESTIMATION 457 19.2.1 GLOBAL SINGLE-USE BIOREACTORS MARKET ESTIMATION, 2025 457 19.2.1.1 Approach 1: Company revenue analysis-based estimation (bottom-up) 457 19.2.1.2 Approach 2: Primary research 459 19.2.1.2.1 Key industry insights 459 19.2.1.3 Approach 3: MnM repository analysis 459 19.2.2 SEGMENTAL MARKET SIZE ESTIMATION, 2025 460 19.3 MARKET GROWTH RATE PROJECTIONS 462 19.4 DATA TRIANGULATION 464 19.5 RESEARCH ASSUMPTIONS 465 19.6 RESEARCH LIMITATIONS & RISK ASSESSMENT 466 20 APPENDIX 467 20.1 DISCUSSION GUIDE 467 20.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 472 20.3 CUSTOMIZATION OPTIONS 474 20.4 RELATED REPORTS 475 20.5 AUTHOR DETAILS 476

TABLE 1 SINGLE-USE BIOREACTORS MARKET: INCLUSIONS AND EXCLUSIONS 44 TABLE 2 SINGLE-USE BIOREACTORS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 58 TABLE 3 COMPARISON OF SINGLE-USE AND MULTI-USE BIOREACTORS 59 TABLE 4 WATER AND ENERGY CONSUMPTION FOR A TYPICAL PROCESS (COMMERCIAL MAB PRODUCTION AT 3 X 2,000 L SCALE) 62 TABLE 5 EXAMPLES OF ORGANIZATIONS INVOLVED IN SU STANDARDS 68 TABLE 6 COMPARISON OF SINGLE-USE BIOPROCESS SYSTEM DISPOSAL OPTIONS 69 TABLE 7 SINGLE-USE BIOREACTORS MARKET: IMPACT OF PORTER’S FIVE FORCES 73 TABLE 8 SINGLE-USE BIOREACTORS MARKET: ROLE IN ECOSYSTEM 79 TABLE 9 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY KEY PLAYER, 2023–2025 (USD) 81 TABLE 10 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY REGION, 2023–2025 (USD) 83 TABLE 11 IMPORT DATA FOR HS CODE 841989, 2021–2025 (USD THOUSAND) 85 TABLE 12 IMPORT DATA FOR HS CODE 841989, 2021–2025 (UNITS) 86 TABLE 13 EXPORT DATA FOR HS CODE 841989, 2021–2025 (USD THOUSAND) 87 TABLE 14 EXPORT DATA FOR HS CODE 841989, 2021–2025 (TONS) 88 TABLE 15 SINGLE-USE BIOREACTORS MARKET: KEY CONFERENCES & EVENTS, 2026–2027 89 TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES 92 TABLE 17 SINGLE-USE BIOREACTORS MARKET: INDICATIVE LIST OF PATENTS, 2026 101 TABLE 18 CASE STUDIES OF AI IMPLEMENTATION IN SINGLE-USE BIOREACTORS MARKET 105 TABLE 19 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN SINGLE-USE BIOREACTORS 106 TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 107 TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108 TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 24 COMPARATIVE ENVIRONMENTAL PROFILE OF SINGLE-USE AND STAINLESS STEEL BIOPROCESSING PLATFORMS ACROSS KEY SUSTAINABILITY INDICATORS 112 TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 116 TABLE 26 KEY BUYING CRITERIA, BY END USER 117 TABLE 27 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 121 TABLE 28 EXAMPLES OF SINGLE-USE BIOREACTOR SYSTEMS 122 TABLE 29 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2024–2031 (USD MILLION) 122 TABLE 30 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 123 TABLE 31 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 32 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124 TABLE 33 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124 TABLE 34 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 35 MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 125 TABLE 36 GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 37 ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 126 TABLE 38 NORTH AMERICA: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 39 EUROPE: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 40 ASIA PACIFIC: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 41 LATIN AMERICA: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 42 MIDDLE EAST: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 128 TABLE 43 GCC COUNTRIES: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 44 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 130 TABLE 45 NORTH AMERICA: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 46 EUROPE: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 47 ASIA PACIFIC: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 48 LATIN AMERICA: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 49 MIDDLE EAST: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 50 GCC COUNTRIES: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 51 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 133 TABLE 52 NORTH AMERICA: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 53 EUROPE: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 54 ASIA PACIFIC: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 55 LATIN AMERICA: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 56 MIDDLE EAST: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 135 TABLE 57 GCC COUNTRIES: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 58 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 137 TABLE 59 NORTH AMERICA: 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 60 EUROPE: 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 61 ASIA PACIFIC: 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 62 LATIN AMERICA: 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 63 MIDDLE EAST: 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 139 TABLE 64 GCC COUNTRIES: 501–1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 65 >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 140 TABLE 66 NORTH AMERICA: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 67 EUROPE: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 68 ASIA PACIFIC: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 69 LATIN AMERICA: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 70 MIDDLE EAST: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 142 TABLE 71 GCC COUNTRIES: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 72 SINGLE-USE BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 144 TABLE 73 SINGLE-USE BAGS MARKET, BY REGION, 2024–2031 (USD MILLION) 144 TABLE 74 NORTH AMERICA: SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 75 EUROPE: SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 76 ASIA PACIFIC: SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 77 LATIN AMERICA: SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 78 MIDDLE EAST: SINGLE-USE BAGS MARKET, BY REGION, 2024–2031 (USD MILLION) 146 TABLE 79 GCC COUNTRIES: SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 80 2D SINGLE-USE BAGS MARKET, BY REGION, 2024–2031 (USD MILLION) 147 TABLE 81 NORTH AMERICA: 2D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 82 EUROPE: 2D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 83 ASIA PACIFIC: 2D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 84 LATIN AMERICA: 2D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 85 MIDDLE EAST: 2D SINGLE-USE BAGS MARKET, BY REGION, 2024–2031 (USD MILLION) 149 TABLE 86 GCC COUNTRIES: 2D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 87 3D SINGLE-USE BAGS MARKET, BY REGION, 2024–2031 (USD MILLION) 150 TABLE 88 NORTH AMERICA: 3D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 89 EUROPE: 3D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 90 ASIA PACIFIC: 3D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 91 LATIN AMERICA: 3D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 92 MIDDLE EAST: 3D SINGLE-USE BAGS MARKET, BY REGION, 2024–2031 (USD MILLION) 152 TABLE 93 GCC COUNTRIES: 3D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 94 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2024–2031 (USD MILLION) 153 TABLE 95 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 96 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 97 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 98 LATIN AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 99 MIDDLE EAST: SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2024–2031 (USD MILLION) 155 TABLE 100 GCC COUNTRIES: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 101 OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 102 NORTH AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 103 EUROPE: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 104 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 105 LATIN AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 106 MIDDLE EAST: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 159 TABLE 107 GCC COUNTRIES: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 108 SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 161 TABLE 109 EXAMPLES OF STIRRED-TANK SINGLE-USE BIOREACTOR SYSTEMS 162 TABLE 110 STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 111 NORTH AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 112 EUROPE: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 113 ASIA PACIFIC: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 114 LATIN AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 115 MIDDLE EAST: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 164 TABLE 116 GCC COUNTRIES: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 117 EXAMPLES OF WAVE-INDUCED SINGLE-USE BIOREACTOR SYSTEMS 166 TABLE 118 WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 166 TABLE 119 NORTH AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 120 EUROPE: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 121 ASIA PACIFIC: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 122 LATIN AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 123 MIDDLE EAST: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 168 TABLE 124 GCC COUNTRIES: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 125 EXAMPLES OF FIXED-BED SINGLE-USE BIOREACTOR SYSTEMS 169 TABLE 126 FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 170 TABLE 127 NORTH AMERICA: FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 128 EUROPE: FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 129 ASIA PACIFIC: FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 130 LATIN AMERICA: FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 131 MIDDLE EAST: FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 172 TABLE 132 GCC COUNTRIES: FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 133 BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 173 TABLE 134 NORTH AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 135 EUROPE: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 136 ASIA PACIFIC: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 137 LATIN AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 138 MIDDLE EAST: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 175 TABLE 139 GCC COUNTRIES: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 140 OTHER SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 177 TABLE 141 NORTH AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 142 EUROPE: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 143 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 144 LATIN AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 145 MIDDLE EAST: OTHER SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 179 TABLE 146 GCC COUNTRIES: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 147 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 181 TABLE 148 SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2024–2031 (USD MILLION) 182 TABLE 149 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 150 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 151 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 152 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 153 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2024–2031 (USD MILLION) 184 TABLE 154 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 155 SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY REGION, 2024–2031 (USD MILLION) 185 TABLE 156 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 157 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 158 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 159 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 160 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY REGION, 2024–2031 (USD MILLION) 187 TABLE 161 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 162 SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY REGION, 2024–2031 (USD MILLION) 189 TABLE 163 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 164 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 165 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 166 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 167 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY REGION, 2024–2031 (USD MILLION) 191 TABLE 168 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 169 SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY REGION, 2024–2031 (USD MILLION) 192 TABLE 170 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 171 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 172 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 173 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 174 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY REGION, 2024–2031 (USD MILLION) 195 TABLE 175 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 176 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 197 TABLE 177 SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY REGION, 2024–2031 (USD MILLION) 198 TABLE 178 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 179 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 180 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 181 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 182 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY REGION, 2024–2031 (USD MILLION) 200 TABLE 183 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 184 SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY REGION, 2024–2031 (USD MILLION) 201 TABLE 185 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 186 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 187 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 188 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 189 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY REGION, 2024–2031 (USD MILLION) 203 TABLE 190 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 191 SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY REGION, 2024–2031 (USD MILLION) 205 TABLE 192 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 193 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 206 TABLE 194 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 206 TABLE 195 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 196 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY REGION, 2024–2031 (USD MILLION) 207 TABLE 197 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 198 SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY REGION, 2024–2031 (USD MILLION) 208 TABLE 199 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 200 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 201 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 210 TABLE 202 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 210 TABLE 203 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY REGION, 2024–2031 (USD MILLION) 211 TABLE 204 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 205 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 213 TABLE 206 SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY REGION, 2024–2031 (USD MILLION) 214 TABLE 207 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 208 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 209 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 210 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 211 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY REGION, 2024–2031 (USD MILLION) 216 TABLE 212 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 213 SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 217 TABLE 214 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 215 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 216 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 217 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 218 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 219 TABLE 219 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 220 TABLE 220 SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 221 TABLE 221 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 221 TABLE 222 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 222 TABLE 223 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 222 TABLE 224 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 225 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 223 TABLE 226 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 227 SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 225 TABLE 228 SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY REGION, 2024–2031 (USD MILLION) 226 TABLE 229 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 226 TABLE 230 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 231 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 232 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 233 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY REGION, 2024–2031 (USD MILLION) 228 TABLE 234 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 235 SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY REGION, 2024–2031 (USD MILLION) 229 TABLE 236 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 237 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 238 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 239 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 240 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY REGION, 2024–2031 (USD MILLION) 231 TABLE 241 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 232 TABLE 242 SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/CONTINUOUS PROCESS MODE, BY REGION, 2024–2031 (USD MILLION) 233 TABLE 243 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/CONTINUOUS PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 244 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/CONTINUOUS PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 245 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/CONTINUOUS PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 246 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/ CONTINUOUS PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 247 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/ CONTINUOUS PROCESS MODE, BY REGION, 2024–2031 (USD MILLION) 235 TABLE 248 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/ CONTINUOUS PROCESS MODE, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 249 SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 237 TABLE 250 SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 238 TABLE 251 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 252 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 239 TABLE 253 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 239 TABLE 254 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 240 TABLE 255 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 240 TABLE 256 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 240 TABLE 257 SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION) 241 TABLE 258 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 259 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 260 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 243 TABLE 261 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 243 TABLE 262 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION) 243 TABLE 263 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 244 TABLE 264 SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 245 TABLE 265 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 266 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 246 TABLE 267 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 246 TABLE 268 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 247 TABLE 269 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 247 TABLE 270 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 247 TABLE 271 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 249 TABLE 272 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 250 TABLE 273 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 251 TABLE 274 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 275 NORTH AMERICA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 276 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 277 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 252 TABLE 278 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 252 TABLE 279 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 253 TABLE 280 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 253 TABLE 281 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 253 TABLE 282 NATIONAL INSTITUTES OF HEALTH FUNDING, FY2024–FY2026 254 TABLE 283 US: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 255 TABLE 284 US: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 285 US: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 286 US: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 287 US: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 256 TABLE 288 US: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 256 TABLE 289 US: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 257 TABLE 290 US: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 257 TABLE 291 US: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 257 TABLE 292 CANADA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 258 TABLE 293 CANADA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 294 CANADA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 295 CANADA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 296 CANADA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 260 TABLE 297 CANADA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 260 TABLE 298 CANADA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 260 TABLE 299 CANADA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 261 TABLE 300 CANADA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 261 TABLE 301 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 302 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 262 TABLE 303 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 304 EUROPE: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 305 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 306 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 263 TABLE 307 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 264 TABLE 308 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 264 TABLE 309 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 264 TABLE 310 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 265 TABLE 311 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 266 TABLE 312 GERMANY: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 313 GERMANY: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 314 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 315 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 267 TABLE 316 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 267 TABLE 317 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 268 TABLE 318 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 268 TABLE 319 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 268 TABLE 320 UK: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 269 TABLE 321 UK: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 322 UK: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 323 UK: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 324 UK: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 271 TABLE 325 UK: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 271 TABLE 326 UK: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 271 TABLE 327 UK: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 272 TABLE 328 UK: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 272 TABLE 329 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 273 TABLE 330 FRANCE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 331 FRANCE: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 332 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 333 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 274 TABLE 334 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 275 TABLE 335 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 275 TABLE 336 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 275 TABLE 337 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 276 TABLE 338 ITALY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 277 TABLE 339 ITALY: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 340 ITALY: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 341 ITALY: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 342 ITALY: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 278 TABLE 343 ITALY: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 278 TABLE 344 ITALY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 279 TABLE 345 ITALY: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 279 TABLE 346 ITALY: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 279 TABLE 347 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 280 TABLE 348 SPAIN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 349 SPAIN: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 350 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 351 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 282 TABLE 352 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 282 TABLE 353 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 282 TABLE 354 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 283 TABLE 355 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 283 TABLE 356 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 284 TABLE 357 REST OF EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 358 REST OF EUROPE: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 359 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 360 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 285 TABLE 361 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 286 TABLE 362 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 286 TABLE 363 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 286 TABLE 364 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 287 TABLE 365 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 289 TABLE 366 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 289 TABLE 367 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 368 ASIA PACIFIC: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 369 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 370 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 291 TABLE 371 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 292 TABLE 372 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 292 TABLE 373 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 292 TABLE 374 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 293 TABLE 375 CHINA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 294 TABLE 376 CHINA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 377 CHINA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 378 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 379 CHINA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 295 TABLE 380 CHINA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 296 TABLE 381 CHINA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 296 TABLE 382 CHINA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 296 TABLE 383 CHINA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 297 TABLE 384 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 298 TABLE 385 SOUTH KOREA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 386 SOUTH KOREA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 387 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 388 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 299 TABLE 389 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 300 TABLE 390 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 300 TABLE 391 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 300 TABLE 392 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 301 TABLE 393 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 302 TABLE 394 JAPAN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 395 JAPAN: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 396 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 397 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 303 TABLE 398 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 304 TABLE 399 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 304 TABLE 400 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 304 TABLE 401 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 305 TABLE 402 INDIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 306 TABLE 403 INDIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 404 INDIA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 405 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 406 INDIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 307 TABLE 407 INDIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 307 TABLE 408 INDIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 308 TABLE 409 INDIA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 308 TABLE 410 INDIA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 308 TABLE 411 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 309 TABLE 412 AUSTRALIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 413 AUSTRALIA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 414 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 415 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 311 TABLE 416 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 311 TABLE 417 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 311 TABLE 418 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 312 TABLE 419 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 312 TABLE 420 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 313 TABLE 421 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 422 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 423 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 424 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 315 TABLE 425 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 315 TABLE 426 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 315 TABLE 427 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 316 TABLE 428 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 316 TABLE 429 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 317 TABLE 430 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 317 TABLE 431 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 432 LATIN AMERICA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 433 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 434 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 319 TABLE 435 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 319 TABLE 436 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 319 TABLE 437 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 320 TABLE 438 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 320 TABLE 439 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 321 TABLE 440 BRAZIL: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 321 TABLE 441 BRAZIL: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 442 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 443 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 322 TABLE 444 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 323 TABLE 445 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 323 TABLE 446 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 323 TABLE 447 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 324 TABLE 448 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 324 TABLE 449 MEXICO: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 450 MEXICO: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 451 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 452 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 326 TABLE 453 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 326 TABLE 454 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 326 TABLE 455 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 327 TABLE 456 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 327 TABLE 457 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 328 TABLE 458 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 328 TABLE 459 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 328 TABLE 460 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 461 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 329 TABLE 462 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 330 TABLE 463 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 330 TABLE 464 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 330 TABLE 465 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 331 TABLE 466 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024–2031 (USD MILLION) 331 TABLE 467 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 332 TABLE 468 MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 469 MIDDLE EAST: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 470 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 333 TABLE 471 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 333 TABLE 472 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 333 TABLE 473 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 334 TABLE 474 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 334 TABLE 475 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 334 TABLE 476 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 335 TABLE 477 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 335 TABLE 478 GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 336 TABLE 479 GCC COUNTRIES: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 336 TABLE 480 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 336 TABLE 481 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 337 TABLE 482 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 337 TABLE 483 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 337 TABLE 484 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 338 TABLE 485 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 338 TABLE 486 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 339 TABLE 487 SAUDI ARABIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 488 SAUDI ARABIA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 489 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 340 TABLE 490 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 340 TABLE 491 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 340 TABLE 492 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 341 TABLE 493 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 341 TABLE 494 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 341 TABLE 495 UAE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 342 TABLE 496 UAE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 342 TABLE 497 UAE: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 343 TABLE 498 UAE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 343 TABLE 499 UAE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 343 TABLE 500 UAE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 344 TABLE 501 UAE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 344 TABLE 502 UAE: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 344 TABLE 503 UAE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 345 TABLE 504 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 345 TABLE 505 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 506 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 507 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 508 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 347 TABLE 509 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 347 TABLE 510 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 347 TABLE 511 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 348 TABLE 512 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 348 TABLE 513 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 349 TABLE 514 REST OF MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 515 REST OF MIDDLE EAST: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 516 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 350 TABLE 517 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 350 TABLE 518 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 351 TABLE 519 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 351 TABLE 520 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 351 TABLE 521 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 352 TABLE 522 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 352 TABLE 523 AFRICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 353 TABLE 524 AFRICA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024–2031 (USD MILLION) 353 TABLE 525 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 353 TABLE 526 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024–2031 (USD MILLION) 354 TABLE 527 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 354 TABLE 528 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 354 TABLE 529 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024–2031 (USD MILLION) 355 TABLE 530 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024–2031 (USD MILLION) 355 TABLE 531 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, JANUARY 2023–JULY 2026 356 TABLE 532 SINGLE-USE BIOREACTORS MARKET: DEGREE OF COMPETITION 360 TABLE 533 SINGLE-USE BIOREACTORS MARKET: REGION FOOTPRINT 364 TABLE 534 SINGLE-USE BIOREACTORS MARKET: PRODUCT FOOTPRINT 365 TABLE 535 SINGLE-USE BIOREACTORS MARKET: TYPE FOOTPRINT 366 TABLE 536 SINGLE-USE BIOREACTORS MARKET: APPLICATION FOOTPRINT 367 TABLE 537 SINGLE-USE BIOREACTORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025 370 TABLE 538 SINGLE-USE BIOREACTORS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT AND REGION, 2025 372 TABLE 539 SINGLE-USE BIOREACTORS MARKET: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 375 TABLE 540 SINGLE-USE BIOREACTORS MARKET: DEALS, JANUARY 2023–JULY 2026 376 TABLE 541 SINGLE-USE BIOREACTORS MARKET: EXPANSIONS, JANUARY 2023–JULY 2026 377 TABLE 542 SARTORIUS AG: COMPANY OVERVIEW 378 TABLE 543 SARTORIUS AG: PRODUCTS OFFERED 379 TABLE 544 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 381 TABLE 545 SARTORIUS AG: DEALS, JANUARY 2023–JULY 2026 381 TABLE 546 SARTORIUS AG: EXPANSIONS, JANUARY 2023–JULY 2026 382 TABLE 547 DANAHER CORPORATION: COMPANY OVERVIEW 384 TABLE 548 DANAHER CORPORATION: PRODUCTS OFFERED 386 TABLE 549 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 388 TABLE 550 DANAHER CORPORATION: DEALS, JANUARY 2023–JULY 2026 388 TABLE 551 DANAHER CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026 389 TABLE 552 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 391 TABLE 553 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 393 TABLE 554 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 394 TABLE 555 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–JULY 2026 395 TABLE 556 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–JULY 2026 396 TABLE 557 MERCK KGAA: COMPANY OVERVIEW 398 TABLE 558 MERCK KGAA: PRODUCTS OFFERED 400 TABLE 559 MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 401 TABLE 560 MERCK KGAA: DEALS, JANUARY 2023–JULY 2026 401 TABLE 561 MERCK KGAA: EXPANSIONS, JANUARY 2023–JULY 2026 402 TABLE 562 AVANTOR, INC.: COMPANY OVERVIEW 404 TABLE 563 AVANTOR, INC.: PRODUCTS OFFERED 406 TABLE 564 AVANTOR, INC.: DEALS, JANUARY 2023–JULY 2026 407 TABLE 565 AVANTOR, INC.: EXPANSIONS, JANUARY 2023–JULY 2026 407 TABLE 566 REPLIGEN CORPORATION: COMPANY OVERVIEW 408 TABLE 567 REPLIGEN CORPORATION: PRODUCTS OFFERED 410 TABLE 568 REPLIGEN CORPORATION: DEALS, JANUARY 2023–JULY 2026 411 TABLE 569 REPLIGEN CORPORATION: EXPANSION, JANUARY 2023–JULY 2026 411 TABLE 570 GETINGE AB: COMPANY OVERVIEW 412 TABLE 571 GETINGE AB: PRODUCTS OFFERED 414 TABLE 572 GETINGE AB: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 415 TABLE 573 GETINGE AB: DEALS, JANUARY 2023–JULY 2026 415 TABLE 574 GETINGE AB: EXPANSIONS, JANUARY 2023–JULY 2026 416 TABLE 575 EPPENDORF SE: COMPANY OVERVIEW 417 TABLE 576 EPPENDORF SE: PRODUCTS OFFERED 418 TABLE 577 EPPENDORF SE: DEALS, JANUARY 2023–JULY 2026 419 TABLE 578 EPPENDORF SE: EXPANSIONS, JANUARY 2023–JULY 2026 419 TABLE 579 PARKER HANNIFIN CORPORATION: COMPANY OVERVIEW 420 TABLE 580 PARKER HANNIFIN CORPORATION: PRODUCTS OFFERED 422 TABLE 581 ENTEGRIS: COMPANY OVERVIEW 423 TABLE 582 ENTEGRIS: PRODUCTS OFFERED 425 TABLE 583 SAINT-GOBAIN: COMPANY OVERVIEW 426 TABLE 584 SAINT-GOBAIN: PRODUCTS OFFERED 427 TABLE 585 SAINT-GOBAIN: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 428 TABLE 586 SAINT-GOBAIN: EXPANSIONS, JANUARY 2023–JULY 2026 428 TABLE 587 CORNING INCORPORATED: COMPANY OVERVIEW 429 TABLE 588 CORNING INCORPORATED: PRODUCTS OFFERED 430 TABLE 589 LONZA: COMPANY OVERVIEW 431 TABLE 590 LONZA: PRODUCTS OFFERED 432 TABLE 591 LONZA: DEALS, JANUARY 2023–JULY 2026 433 TABLE 592 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.: COMPANY OVERVIEW 434 TABLE 593 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.: PRODUCTS OFFERED 434 TABLE 594 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 435 TABLE 595 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.: EXPANSIONS, JANUARY 2023–JULY 2026 435 TABLE 596 ZACROS CORPORATION: COMPANY OVERVIEW 436 TABLE 597 ZACROS CORPORATION: PRODUCTS OFFERED 437 TABLE 598 ADOLF KÜHNER AG: COMPANY OVERVIEW 438 TABLE 599 OMNIBRX BIOTECHNOLOGIES PVT LTD.: COMPANY OVERVIEW 439 TABLE 600 NEW HORIZON BIOTECHNOLOGY, INC.: COMPANY OVERVIEW 440 TABLE 601 PBS BIOTECH, INC.: COMPANY OVERVIEW 441 TABLE 602 BBI-BIOTECH GMBH: COMPANY OVERVIEW 442 TABLE 603 ABEC, INC.: COMPANY OVERVIEW 443 TABLE 604 ESCO LIFESCIENCES GROUP: COMPANY OVERVIEW 444 TABLE 605 DISTEK, INC.: COMPANY OVERVIEW 445 TABLE 606 SATAKE MULTIMIX CORPORATION: COMPANY OVERVIEW 446 TABLE 607 CELL CULTURE COMPANY, LLC: COMPANY OVERVIEW 447 TABLE 608 MICRODIGITAL CO., LTD.: COMPANY OVERVIEW 448 TABLE 609 BIONET: COMPANY OVERVIEW 449 TABLE 610 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW 450 TABLE 611 SOLIDA BIOTECH GMBH: COMPANY OVERVIEW 451 TABLE 612 G&G TECHNOLOGIES, INC.: COMPANY OVERVIEW 451 TABLE 613 PHARMNXT BIOTECH: COMPANY OVERVIEW 452 TABLE 614 TOFFLON LIFE SCIENCE CO., LTD.: COMPANY OVERVIEW 452 TABLE 615 SHANGHAI LEPURE BIOTECH CO., LTD.: COMPANY OVERVIEW 453 TABLE 616 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 463 TABLE 617 RISK ASSESSMENT 466 FIGURE 1 SINGLE-USE BIOREACTORS MARKET SEGMENTATION & REGIONS COVERED 43 FIGURE 2 SINGLE-USE BIOREACTORS MARKET: YEARS CONSIDERED 45 FIGURE 3 MARKET SCENARIO 48 FIGURE 4 GLOBAL SINGLE-USE BIOREACTORS MARKET, 2024–2031 48 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, 2023–2026 49 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF SINGLE-USE BIOREACTORS MARKET 50 FIGURE 7 HIGH-GROWTH SEGMENTS IN SINGLE-USE BIOREACTORS MARKET, 2026–2031 51 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN SINGLE-USE BIOREACTORS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 52 FIGURE 9 INCREASING BIOLOGICS, BIOSIMILARS, VACCINES, AND CELL & GENE THERAPY MANUFACTURING EXPANSION TO PROPEL MARKET GROWTH 53 FIGURE 10 US AND SINGLE-USE BIOREACTOR SYSTEMS SEGMENT COMMANDED LARGEST MARKET SHARES IN 2025 54 FIGURE 11 CHINA TO REGISTER HIGHER CAGR DURING FORECAST PERIOD 55 FIGURE 12 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 56 FIGURE 13 SINGLE-USE BIOREACTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57 FIGURE 14 ANNUAL PRODUCTION CAPACITY: SINGLE-PRODUCT FACILITY VS. MULTI-PRODUCT FACILITY 60 FIGURE 15 COMPARISON BETWEEN SINGLE-PRODUCT AND MULTI-PRODUCT FACILITIES 61 FIGURE 16 BIOSIMILAR APPROVALS & LAUNCHES, 2015–2025 63 FIGURE 17 NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US/EU, 2012−2025 63 FIGURE 18 SINGLE-USE BIOREACTORS MARKET: PORTER’S FIVE FORCES ANALYSIS 72 FIGURE 19 GLOBAL GDP GROWTH, 2020–2030 75 FIGURE 20 SINGLE-USE BIOREACTORS MARKET: VALUE CHAIN ANALYSIS 76 FIGURE 21 SINGLE-USE BIOREACTORS MARKET ECOSYSTEM 78 FIGURE 22 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY TYPE, 2023–2025 (USD) 82 FIGURE 23 AVERAGE SELLING PRICE OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY REGION, 2025 (USD) 84 FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 90 FIGURE 25 TOP APPLICANTS/OWNERS (COMPANIES) FOR SINGLE-USE BIOREACTORS PATENTS, 2015–2025 100 FIGURE 26 IMPACT OF AI/GEN AI ON SINGLE-USE BIOREACTORS MARKET 104 FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-USE BIOREACTOR PRODUCTS 115 FIGURE 28 KEY BUYING CRITERIA, BY END USER 117 FIGURE 29 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SNAPSHOT 250 FIGURE 30 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET SNAPSHOT 288 FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, 2021–2025 (USD BILLION) 358 FIGURE 32 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, 2025 359 FIGURE 33 SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 362 FIGURE 34 SINGLE-USE BIOREACTORS MARKET: COMPANY FOOTPRINT 363 FIGURE 35 SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 369 FIGURE 36 EV/EBITDA OF KEY VENDORS, 2026 373 FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2026 373 FIGURE 38 SINGLE-USE BIOREACTORS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 374 FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2025) 379 FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 385 FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 392 FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2025) 399 FIGURE 43 AVANTOR, INC.: COMPANY SNAPSHOT (2025) 405 FIGURE 44 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2025) 409 FIGURE 45 GETINGE AB: COMPANY SNAPSHOT (2025) 413 FIGURE 46 EPPENDORF SE: COMPANY SNAPSHOT (2025) 417 FIGURE 47 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2025) 421 FIGURE 48 ENTEGRIS: COMPANY SNAPSHOT (2025) 424 FIGURE 49 SAINT-GOBAIN: COMPANY SNAPSHOT (2025) 426 FIGURE 50 CORNING INCORPORATED: COMPANY SNAPSHOT (2025) 429 FIGURE 51 LONZA: COMPANY SNAPSHOT (2025) 432 FIGURE 52 ZACROS CORPORATION: COMPANY SNAPSHOT (2025) 436 FIGURE 53 SINGLE-USE BIOREACTORS MARKET: RESEARCH DESIGN 454 FIGURE 54 SINGLE-USE BIOREACTORS MARKET: BREAKDOWN OF PRIMARIES 456 FIGURE 55 GLOBAL SINGLE-USE BIOREACTORS MARKET ESTIMATION, 2025 457 FIGURE 56 SINGLE-USE BIOREACTORS MARKET: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) (2025) 458 FIGURE 57 ILLUSTRATIVE EXAMPLE OF SARTORIUS AG: REVENUE ANALYSIS (2025) 458 FIGURE 58 SINGLE-USE BIOREACTORS MARKET: INSIGHTS FROM PRIMARIES 459 FIGURE 59 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 460 FIGURE 60 SINGLE-USE BIOREACTORS MARKET: CAGR PROJECTIONS 462 FIGURE 61 SINGLE-USE BIOREACTORS MARKET: DATA TRIANGULATION 464

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Single-Use Bioreactors Market by Product [System (By Scale), Bags (2D, 3D), Assemblies], Type (Stirred Tank), Cell Type (Mammalian, Bacterial, Yeast), Molecule (mAbs, Vaccines, CGT), Process Mode, Application, Competition, Region - Global Forecast to 2031

授權報價

報告摘要

同分類最新報告（醫療與生命科學）